Intravenous Immunoglobulin Controls Th17 Cell-Mediated Osteoclastogenesis
Article in Immune Network (January 2019)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models
Article in Molecular Immunology (December 2018)
Analysis of Characteristics Similar to Autoimmune Disease in Keloid Patients
Article in Aesthetic Plastic Surgery (August 2015)